Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.7824
+0.073410.35%
Post-market: 0.7577-0.0247-3.16%19:51 EDT
Volume:323.02K
Turnover:249.22K
Market Cap:36.57M
PE:-0.87
High:0.8000
Open:0.6969
Low:0.6958
Close:0.7090
Loading ...
Sep 20, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 16, 2021

Major Issues Report

8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 03, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 25, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 19, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
May 10, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 07, 2021

Major Issues Report

8-K - Current report
May 07, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 19, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 15, 2021

Major Issues Report

8-K - Current report
Mar 24, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]